Bellevue Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5M | Buy |
8,230,870
+853,578
| +12% | +$2.95M | 0.63% | 41 |
|
|
2025
Q1 | $19.3M | Hold |
7,377,292
| – | – | 0.43% | 52 |
|
|
2024
Q4 | $30.4M | Buy |
7,377,292
+108
| +0% | +$445 | 0.59% | 42 |
|
|
2024
Q3 | $52.2M | Buy |
7,377,184
+1,000,069
| +16% | +$7.08M | 0.85% | 29 |
|
|
2024
Q2 | $41.6M | Buy |
6,377,115
+450,497
| +8% | +$2.94M | 0.68% | 38 |
|
|
2024
Q1 | $49.2M | Sell |
5,926,618
-9,464
| -0.2% | -$78.6K | 0.75% | 40 |
|
|
2023
Q4 | $65.4M | Buy |
5,936,082
+1,051,082
| +22% | +$11.6M | 1% | 30 |
|
|
2023
Q3 | $41.1M | Buy |
4,885,000
+714,200
| +17% | +$6.01M | 0.66% | 46 |
|
|
2023
Q2 | $52.4M | Sell |
4,170,800
-1,800
| -0% | -$22.6K | 0.75% | 40 |
|
|
2023
Q1 | $68.7M | Sell |
4,172,600
-32,220
| -0.8% | -$531K | 1% | 35 |
|
|
2022
Q4 | $62.8M | Hold |
4,204,820
| – | – | 0.83% | 37 |
|
|
2022
Q3 | $94.1M | Buy |
4,204,820
+172,558
| +4% | +$3.86M | 1.35% | 21 |
|
|
2022
Q2 | $67.5M | Buy |
4,032,262
+113,300
| +3% | +$1.9M | 0.95% | 36 |
|
|
2022
Q1 | $117M | Sell |
3,918,962
-187,000
| -5% | -$5.6M | 1.36% | 22 |
|
|
2021
Q4 | $126M | Buy |
4,105,962
+350,000
| +9% | +$10.7M | 1.3% | 22 |
|
|
2021
Q3 | $118M | Buy |
3,755,962
+1,115,000
| +42% | +$35.2M | 1.2% | 25 |
|
|
2021
Q2 | $96.6M | Buy |
2,640,962
+709,618
| +37% | +$26M | 0.94% | 34 |
|
|
2021
Q1 | $66.8M | Buy |
1,931,344
+521,987
| +37% | +$18M | 0.71% | 49 |
|
|
2020
Q4 | $58.6M | Buy |
1,409,357
+109,357
| +8% | +$4.54M | 0.67% | 46 |
|
|
2020
Q3 | $55.4M | Buy |
+1,300,000
| New | +$55.4M | 0.77% | 39 |
|